Search

everythinglearnresearchcommunity

for

Search:↓

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Pertussis toxin may contribute to hair loss in alopecia areata.

MicroRNAs could help assess and manage multiple chronic diseases.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Terminalia chebula fruit extract helps hair growth by reducing DHT and boosting hair cell activity.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Cholesterol affects coronavirus spread and could be a target for treatment.

Swellable microneedles could improve drug delivery and diagnostics but need more research on materials and technology integration.

FGF22 helps hair follicle stem cells grow and develop.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Enhancing Tregs can protect against alopecia areata.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.